#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16418	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2116	771.2	0	.	n	.	0	C451T	SNP	451	451	C	698	698	T	973	T	895	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16418	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2116	771.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1431	1431	C	967	C,T	872,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29528	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3526	834.5	0	.	n	.	0	T695C	SNP	695	695	T	1016	1016	C	904	C,T	807,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29528	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3526	834.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2292	2292	C	923	C	826	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29528	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3526	834.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2366	2366	A	921	A,G	850,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29528	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3526	834.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2918	2918	C	873	C,A	791,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29528	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3526	834.5	0	HET	.	.	.	G2616A,T	.	2616	2616	G	2937	2937	G	925	G,A,T	655,178,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29528	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3526	834.5	0	HET	.	.	.	A1638G	.	1638	1638	A	1959	1959	A	934	A,G	656,190	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2308	folP	855	855	100.0	folP.l6.c4.ctg.1	1475	155.3	1	SNP	p	R229S	1	.	.	685	687	AGC	991	993	AGC	225;227;228	A;G;C	208;208;207	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5788	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3378	170.7	1	SNP	p	S91F	1	.	.	271	273	TTC	621	623	TTC	200;199;197	T;T;C	183;181;180	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5788	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3378	170.7	1	SNP	p	D95G	1	.	.	283	285	GGC	633	635	GGC	194;193;193	G;G;C	179;178;177	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5788	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3378	170.7	1	SNP	p	G95N	0	.	.	283	285	GGC	633	635	GGC	194;193;193	G;G;C	179;178;177	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1732	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1301	132.5	1	SNP	p	G45D	0	.	.	133	135	GGC	481	483	GGC	250;249;249	G;G;C,A	222;220;221,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	864	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	901	94.7	0	.	n	.	0	A197.	DEL	197	197	A	521	521	A	204	A	179	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5558	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2983	185.6	1	SNP	p	D86N	0	.	.	256	258	GAC	595	597	GAC	208;209;208	G,A;A;C	195,1;195;196	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5558	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2983	185.6	1	SNP	p	R87W	0	.	.	259	261	CGT	598	600	CGT	205;205;206	C;G;T	193;192;193	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5558	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2983	185.6	1	SNP	p	R87I	0	.	.	259	261	CGT	598	600	CGT	205;205;206	C;G;T	193;192;193	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5558	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2983	185.6	1	SNP	p	S87R	1	.	.	259	261	CGT	598	600	CGT	205;205;206	C;G;T	193;192;193	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5558	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2983	185.6	1	SNP	p	S88P	0	.	.	262	264	TCC	601	603	TCC	204;206;205	T;C;C	192;194;192	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4822	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2602	184.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1518	1520	GGC	244;239;236	G;G;C	222;217;210	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4564	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	181.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1264	1266	GCC	253;256;258	G;C;C	231;233;233	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4564	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	181.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1267	1269	ATG	256;259;259	A;T;G	234;236;235	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4564	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	181.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1279	1281	ACC	270;272;274	A;C;C	247;252;250	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4564	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	181.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1279	1281	ACC	270;272;274	A;C;C	247;252;250	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4564	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	181.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1780	1782	ACC	256;255;255	A;C;C	232;233;232	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4564	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	181.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1834	1836	GCG	245;246;244	G;C;G	220;220;215	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4564	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	181.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1834	1836	GCG	245;246;244	G;C;G	220;220;215	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4564	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	181.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1957	1959	GGT	208;206;205	G;G,A;T,A	180;177,1;174,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4564	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	181.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1966	1968	AGC	194;191;189	A;G;C,A,T	168;167;164,1,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4564	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	181.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1984	1986	CCG	164;165;164	C,G;C,G;G	128,9;125,1;123	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6086	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3011	201.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1573	1575	CCG	232;230;229	C;C;G,A	195;201;195,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2116	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1789	117.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	591	591	C	132	C	114	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3088	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1613	190.6	0	.	p	.	0	G210R	NONSYN	628	630	GGA	906	908	AGA	276;272;271	A;G;A,G	252;247;244,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3088	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1613	190.6	0	.	p	.	0	S217G	NONSYN	649	651	AGT	927	929	GGT	274;272;275	G;G;T,G	248;246;248,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3088	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1613	190.6	1	SNP	p	G120K	1	.	.	358	360	AAG	636	638	AAG	230;226;226	A;A,C;G,A	212;213,1;210,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3088	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1613	190.6	1	SNP	p	A121N	1	.	.	361	363	AAC	639	641	AAC	227;225;226	A;A;C	211;208;212	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3088	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1613	190.6	1	SNP	p	N121D	0	.	.	361	363	AAC	639	641	AAC	227;225;226	A;A;C	211;208;212	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11896	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4936	240.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1230	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	963	126.7	1	SNP	p	V57M	1	.	.	169	171	ATG	516	518	ATG	268;270;272	A;T;G	242;244;249	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
